Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis
Cyra E Leurs(Vrije Universiteit Amsterdam), Helga E. de Vries(Amsterdam Neuroscience), Melissa A Lopes Pinheiro(Amsterdam Neuroscience), A. J. C. Eijlers(Amsterdam Neuroscience), Monique Mulder(Erasmus MC), Lisanne J. Balk(Amsterdam UMC Location Vrije Universiteit Amsterdam), Sandra den Hoedt(Erasmus MC), Laura Wierts(Amsterdam Neuroscience), Menno M. Schoonheim(Amsterdam Neuroscience), Joep Killestein(Amsterdam UMC Location Vrije Universiteit Amsterdam), Bernard M.J. Uitdehaag(Amsterdam Neuroscience)
Cited by 10
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity
|PLoS ONE|2010|621
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
|The Lancet Neurology|2017|572